| |
| |
|
| Insider
Information: |
Wentworth Kerry |
| Relationship: |
Chief Regulatory Officer |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
57,410 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,461 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
57,410 |
|
|
| Total
Value |
$25,461 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -91.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agenus Inc |
AGEN |
VP, Clinical, Reg & Qual |
2014-02-26 |
57,410 |
|
0 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
Chief Regulatory Officer |
2021-11-19 |
0 |
2021-11-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2021-11-19 |
4 |
D |
$8.50 |
$1,197,166 |
D/D |
(140,843) |
0 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2010-01-19 |
4 |
A |
$0.90 |
$122,779 |
D/D |
136,421 |
242,853 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin., Reg. & Qual. |
• – – |
2009-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
115,200 |
136,372 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2010-01-20 |
4 |
S |
$0.85 |
$87,316 |
D/D |
(102,316) |
140,537 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2010-01-20 |
4/A |
AS |
$0.85 |
$87,316 |
D/D |
(102,316) |
140,537 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2020-07-16 |
4 |
A |
$0.00 |
$0 |
D/D |
38,750 |
120,180 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
50,607 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
81,061 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
143,767 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2011-01-20 |
4 |
A |
$0.94 |
$27,161 |
D/D |
28,895 |
172,983 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin., Reg. and Qual. |
• – – |
2009-06-25 |
4 |
S |
$1.97 |
$49,250 |
D/D |
(25,000) |
21,172 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP Reg Aff and Clinical Ops |
• – – |
2008-07-10 |
4 |
A |
$0.00 |
$0 |
D/D |
24,018 |
31,025 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP Reg Aff and Clinical Ops |
• – – |
2009-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
24,017 |
54,014 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
• – – |
2012-01-03 |
4 |
A |
$2.17 |
$48,003 |
D/D |
22,121 |
37,599 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin., Reg. & Qual. |
• – – |
2009-07-16 |
4 |
S |
$1.62 |
$32,849 |
D/D |
(20,302) |
102,799 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2011-03-09 |
4 |
A |
$0.98 |
$17,868 |
D/D |
18,233 |
195,383 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
• – – |
2012-06-21 |
4 |
D |
$5.05 |
$74,659 |
D/D |
(14,784) |
30,283 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
• – – |
2012-06-19 |
4 |
A |
$5.26 |
$74,445 |
D/D |
14,153 |
59,218 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
• – – |
2012-06-20 |
4 |
D |
$4.99 |
$70,613 |
D/D |
(14,151) |
45,067 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin., Reg. & Qual. |
• – – |
2009-07-15 |
4 |
S |
$1.76 |
$23,397 |
D/D |
(13,271) |
123,101 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
• – – |
2011-12-29 |
4 |
S |
$2.01 |
$17,967 |
D/D |
(8,939) |
15,478 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2018-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
12,307 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP Reg Aff and Clinical Ops |
• – – |
2009-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,907 |
32,579 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP Reg Affairs & Clinical Ops |
• – – |
2008-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,906 |
8,467 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP Reg Aff and Clinical Ops |
• – – |
2009-01-10 |
4 |
D |
$0.46 |
$3,607 |
D/D |
(7,842) |
46,172 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
